Citations

Showing 10 of 108135 citations.

Premature Myocardial Infarction in the Middle East and North Africa: Rationale for the Gulf PREVENT Study
Dugani, Sagar B. , Damilig, Karisamae, Atos, Jean, Mohamed, Eshraga O., Callachan, Edward L., Farukhi, Zareen , Shaikh, Arshia, Elfatih, Abubaker , Yusef, Salwa, Hydoub, Yousif M. , Moorthy, M. Vinayaga , Mora, Bassem, Alawadhi, Ahlam, Issac, Robin, Saleh, Abdulkarim, Al‐Mulla, Arif, Mora, Samia , Hydoub, Yousif M , Dugani, Sagar B , Mora, Samia , Murad, Waheed, Alsheikh-Ali, Alawi A.A.

Mayo Clinic

Angiology | May 27, 2019 | Volume: 71 | Issue: 1 | Pages: 17-26

10.1177/0003319719849737 | PMID 31129986 Get It

The Middle East and North Africa (MENA) region has a high burden of morbidity and mortality due to premature (≤55 years in men; ≤65 years in women) myocardial infarction (MI) and acute coronary syndrome (ACS). Despite this, the prevalence of risk factors in patients presenting with premature MI or ACS is incompletely described. We compared lifestyle, clinical risk factors, and biomarkers associated with premature MI/ACS in the MENA region with selected non-MENA high-income countries. We identified English-language, peer-reviewed publications through PubMed (up to March 2018). We used the World Bank classification system to categorize countries. Patients with premature MI/ACS in the MENA region had a higher prevalence of smoking than older patients with MI/ACS but a lower prevalence of diabetes, hypertension, and dyslipidemia. Men with premature MI/ACS had a higher prevalence of smoking than women but a lower prevalence of diabetes and hypertension. The MENA region had sparse data on lifestyle, diet, psychological stress, and physical activity. To address these knowledge gaps, we initiated the ongoing Gulf Population Risks and Epidemiology of Vascular Events and Treatment (Gulf PREVENT) case–control study to improve primary and secondary prevention of premature MI in the United Arab Emirates, a high-income country in the MENA region.
Risk Factors for Development of Canine and Human Osteosarcoma: A Comparative Review
Makielski, Kelly M. , Mills, Lauren J. , Sarver, Aaron L. , Henson, Michael S. , Spector, Logan G. , Naik, Shruthi , Modiano, Jaime F. , Modiano, Jaime F , Makielski, Kelly M

Mayo Clinic

Veterinary Sciences | May 26, 2019 | Volume: 6 | Issue: 2 | Pages: 48

10.3390/vetsci6020048 | PMID 31130627 Get It

Osteosarcoma is the most common primary tumor of bone. Osteosarcomas are rare in humans, but occur more commonly in dogs. A comparative approach to studying osteosarcoma has highlighted many clinical and biologic aspects of the disease that are similar between dogs and humans; however, important species-specific differences are becoming increasingly recognized. In this review, we describe risk factors for the development of osteosarcoma in dogs and humans, including height and body size, genetics, and conditions that increase turnover of bone-forming cells, underscoring the concept that stochastic mutational events associated with cellular replication are likely to be the major molecular drivers of this disease. We also discuss adaptive, cancer-protective traits that have evolved in large, long-lived mammals, and how increasing size and longevity in the absence of natural selection can account for the elevated bone cancer risk in modern domestic dogs.
Efficacy and safety of curcumin in primary sclerosing cholangitis: an open label pilot study
Eaton, John E. , Nelson, Kevin M., Gossard, Andrea A., Carey, Elizabeth J. , Lindor, Keith D. , Tabibian, James H. , LaRusso, Nicholas F.

Mayo Clinic

Scandinavian Journal of Gastroenterology | May 26, 2019 | Volume: 54 | Issue: 5 | Pages: 633-639

10.1080/00365521.2019.1611917 | PMID 31131678 Get It

Association between mild hyperthyrotropinemia and hypercholesterolemia in children with severe obesity
Iqbal, Anoop Mohamed, Lteif, Aida, Kumar, Seema , Lteif, Aida N

Mayo Clinic

Journal of Pediatric Endocrinology and Metabolism | May 26, 2019 | Volume: 32 | Issue: 6 | Pages: 561-568

10.1515/jpem-2018-0519 | PMID 31129653 Get It

Abstract Background Severe obesity is associated with a number of cardiometabolic risk factors. Thyroid-stimulating hormone (TSH) levels are often slightly increased in children with obesity. The clinical significance of the mild elevation in TSH in children with obesity is unclear. Objective To examine the association between TSH and lipids in children with severe obesity. Methods We performed a retrospective analysis of records of children with severe obesity with simultaneous measurements of TSH and lipids. Children with TSH <0.3 mIU/L and ≥10 mIU/L were excluded. The relationship between TSH and lipids was evaluated using univariate/multiple variable linear and logistic regression. Results The study included 834 children (age 13.8 ± 4.1 years, males 46%, body mass index [BMI]: 36.9 ± 7.6 kg/m2; BMI z-score 2.6 ± 0.4). Seventy-four (8.9%) children had TSH between 5 and <10 mIU/L (high TSH [HTSH]). TSH was positively associated with non-high-density lipoprotein (HDL) cholesterol (β: 1.74; 95% confidence interval [CI] 0.29–3.20, p = 0.02). Total cholesterol and non-HDL cholesterol were higher in males with HTSH compared to those with normal TSH (175.5 vs. 163.5 mg/dL, p = 0.02 and 133.7 vs. 121.4 mg/dL, p = 0.02, respectively). The odds of elevated non-HDL cholesterol (≥145 mg/dL) was higher in males with HTSH relative to those with normal TSH (odds ratio [OR]: 2.78; 95% CI 1.35–5.69, p = 0.005). Conclusions TSH levels were positively associated with non-HDL cholesterol in children with severe obesity. Males with mildly elevated TSH had higher total cholesterol and non-HDL cholesterol compared to males with normal TSH. Further studies are warranted to determine if levothyroxine therapy would result in improvement in total cholesterol or non-HDL cholesterol in children with severe obesity with mildly elevated TSH.
Long‐Term Outcomes in Patients With Turner Syndrome: A 68‐Year Follow‐Up
Fuchs, Margaret , Jost, Christine Attenhofer, Babovic‐Vuksanovic, Dusica , Connolly, Heidi M. , Egbe, Alexander C. , Fuchs, Margaret M , Attenhofer Jost, Christine

Mayo Clinic

Journal of the American Heart Association | May 25, 2019 | Volume: 8 | Issue: 11 | Pages: No page available

10.1161/jaha.118.011501 | PMID 31131660 Get It

Background Turner syndrome ( TS ) is the most common sex chromosome abnormality in women and is associated with increased morbidity and mortality. We describe long‐term outcomes in a large cohort of patients with TS . Methods and Results Retrospective review of patients with TS followed at Mayo Clinic Rochester from 1950 to 2017 was performed. Clinical, imaging, surgical, and genetic data were analyzed. Survival analysis was performed with the Kaplan–Meier method using age‐ and sex‐matched Olmsted County residents as the reference group. The study cohort comprised 317 patients with TS . Average age at diagnosis was 9 (range, 2–12) years, genetic testing was performed in 202 (64%), and pure monosomy X was present in 75 (37%). Congenital heart disease occurred in 131 (41%), with the most frequent lesions being bicuspid aortic valve (n=102, 32%) and coarctation of the aorta (n=43, 14%). Ascending aortic dilation was common, with mean aortic root size index 2 cm/m 2 , and aortic dissection occurred in 6 (2%) patients. The average follow‐up was 11 (range, 2–26) years, yielding 3898 patient‐years, and during this period 46 (14%) patients died; mean age at the time of death was 53±17 years. Patients with TS had reduced survival compared with the control group (82% versus 94% at 30 years; P <0.001), and the leading causes of death were cardiovascular disease, liver disease, and malignancy. Conclusions Patients with TS have reduced survival compared with age‐matched controls, and cardiovascular disease is the major cause of death. Further studies are required to determine if targeted cardiovascular risk factor modification will result in improved survival in this population.
Predicting the Therapeutic Efficacy of Laser Peripheral Iridotomy for Individuals With Asymptomatic Narrow Angle: The Triple Hump Sign
Frota, Thalyta, Gracitelli, Carolina P B , Prata, Tiago S. , Paranhos, Augusto

Mayo Clinic

Journal of Glaucoma | May 25, 2019 | Volume: 28 | Issue: 8 | Pages: e145-e145

10.1097/ijg.0000000000001292 | PMID 31135588 Get It

Transthyretin Amyloidosis Presenting With Upper-Extremity Neuropathy and Paucity of Autonomic Impairment
Devarapalli, Sandeep, Zhou, Daniel J. , Dyck, P. James B. , Piccione, Ezequiel

Mayo Clinic

Journal of Clinical Neuromuscular Disease | May 25, 2019 | Volume: 20 | Issue: 4 | Pages: 207-209

10.1097/cnd.0000000000000238 | PMID 31135624 Get It

Abstract We report a 73-year-old man with Val142Ile transthyretin (TTR) amyloidosis and an atypical clinical presentation of upper-extremity–predominant neuropathy without significant autonomic or cardiac involvement. TTR familial amyloid polyneuropathy commonly presents as length-dependent sensorimotor polyneuropathy with marked and early autonomic involvement. Multiple pathogenic mutations in TTR gene have been identified, of which Val50Met is commonly associated with TTR familial amyloid polyneuropathy, and Val142Ile is commonly associated with familial amyloid cardiomyopathy. Our patient is from a nonendemic region, without family history for amyloidosis. Predominant upper-extremity neuropathy, without significant cardiac or autonomic involvement, distinguishes this case from previously reported Val142Ile-mutated TTR amyloidosis.
18F-FDG PET/CT Imaging of Trichoblastic Carcinoma With Nodal Metastasis
Seetharam, ­Mahesh , Ocal, Tolgay I., Nguyen, Ba D.

Mayo Clinic

Clinical Nuclear Medicine | May 25, 2019 | Volume: 44 | Issue: 7 | Pages: e423-e424

10.1097/rlu.0000000000002622 | PMID 31135519 Get It

Abstract Trichoblastic carcinoma is an uncommon malignant neoplasm arising from follicular germinative cells. The high-grade trichoblastic carcinoma has been reported with lymphatic and hematogenous dissemination. The authors present a 59-year-old man with gluteal cleft trichoblastic carcinoma and highlight the useful role of serial 18F-FDG PET/CT examinations in the demonstration of initial and subsequent nodal metastasis in the inguina and pelvis.
Does Argininosuccinate Synthase 1 (ASS1) Immunohistochemistry Predict an Increased Risk of Hemorrhage for Hepatocellular Adenomas?
Lehrke, Heidi D., Treeck, Benjamin J. Van , Allende, Daniela , Denham, Laura, Moreira, Roger K. , Mounajjed, Taofic, Naini, Bita V. , Smoot, Rory L. , Zreik, Riyam , Jenkins, Sarah M. , Graham, Rondell P. , Smoot, Rory L , Graham, Rondell P , González, Raul S.

Mayo Clinic

Applied Immunohistochemistry & Molecular Morphology | May 25, 2019 | Volume: 28 | Issue: 6 | Pages: 464-470

10.1097/pai.0000000000000774 | PMID 31135443 Get It

Hepatocellular adenomas (HCAs) often pursue an innocuous clinical course. Recent work has elucidated important subtypes of HCA and biomarkers to identify them, including HCA at an increased risk for malignant transformation. Another key complication of HCAs is the risk of spontaneous tumoral hemorrhage, which may be life-threatening. Identification of a predictive biomarker for this clinical complication would therefore be of clinical value. It has been suggested that Argininosuccinate Synthase 1 (ASS1) immunohistochemistry (IHC) identifies HCA with a high propensity for hemorrhage. The aim of our study was to validate ASS1 IHC as a predictive marker of hemorrhage. Eighty-nine HCAs were collected for ASS1 IHC and subtyped according to published criteria. Clinical records were examined for evidence of tumoral hemorrhage. Twenty-one (23.6%) HCAs were complicated by clinically detected hemorrhage and were more likely to be resected (P=0.0002). Hemorrhage complicated all WHO subtypes of HCA. There was no association between hemorrhage and HCA subtype (P=0.92). Neither the distribution of ASS1 expression nor the intensity of ASS1 expression compared to normal liver showed a significant association with hemorrhage (P=0.051 and 0.34). Interlaboratory comparison of 8 cases showed good agreement regarding the intensity (6/8 and 7/8) and distribution of staining (7/8 and 7/8) across 3 laboratories performing ASS1 IHC. In conclusion, all subtypes of HCA may be complicated by hemorrhage. ASS1 IHC expression did not correlate with hemorrhagic complications. Caution is prudent before routine implementation of ASS1 IHC in clinical practice.